The Fluid Therapy Market size was valued at USD 10,212 million in 2021 which is expected to grow at a CAGR of 6.2% from 2022-2028. Fluid Therapy is a type of therapy that includes inoculation of the crystalloid mixture into patients whose circulating blood volume is decreased. This therapy can also be used for treating dehydration to substitute the fluid loss from the body. This therapy helps to meet the fluid requirements for those patients who cannot take fluids orally. The increasing prevalence of infectious and chronic diseases such as cancer, gastrointestinal tract, nephrology, and diabetes and the increasing number of minor invasive surgeries are some primary factors that can boost the global fluid therapy market. Apart from this, an increase in health consciousness among individuals, and expansion in marketable pipelines can also accelerate the market in the future. Another factor that drives the fluid therapy market is the growing research and development in pharmaceutical and biotechnological industries to come up with new treatment methods for certain diseases such as sepsis, hypovolemia, colic and shock, and the launch of novel services and products. Moreover, technological advancement and an increase in healthcare expenditure can future drive market growth. However, some factors such as the high purchasing cost of fluid therapy instruments, lack of technical skills, and lack of awareness about this therapy among the population can restrain the growth of the market. Another factor that can hinder the growth of the market is concern about plastic bags releasing toxic chemicals into the veins of the patient. Moreover, the usage of single-use disposable accessories and devices and the developing market are expected to produce lucrative opportunities for the global market.
Recent Market Developments:
In June 2020, Fresenius Medical care planned to open more than 100 new transitional care units in the US to empower people with kidney diagnosis, home dialysis, and treatment.
In December 2020, a Carpediem System, a neonatal and pediatric acute dialysis machine, was launched by Medtronic.